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Abstract
Background: Chest pain is the second most common chief complaint in North American
emergency departments. Data from the U.S. suggest that 2.1% of patients with acute myocardial
infarction and 2.3% of patients with unstable angina are misdiagnosed, with slightly higher rates
reported in a recent Canadian study (4.6% and 6.4%, respectively). Information obtained from the
history, 12-lead ECG, and a single set of cardiac enzymes is unable to identify patients who are safe
for early discharge with sufficient sensitivity. The 2007 ACC/AHA guidelines for UA/NSTEMI do
not identify patients at low risk for adverse cardiac events who can be safely discharged without
provocative testing. As a result large numbers of low risk patients are triaged to chest pain
observation units and undergo provocative testing, at significant cost to the healthcare system.
Clinical decision rules use clinical findings (history, physical exam, test results) to suggest a
diagnostic or therapeutic course of action. Currently no methodologically robust clinical decision
rule identifies patients safe for early discharge.
Methods/design: The goal of this study is to derive a clinical decision rule which will allow
emergency physicians to accurately identify patients with chest pain who are safe for early
discharge. The study will utilize a prospective cohort design. Standardized clinical variables will be
collected on all patients at least 25 years of age complaining of chest pain prior to provocative
testing. Variables strongly associated with the composite outcome acute myocardial infarction,
revascularization, or death will be further analyzed with multivariable analysis to derive the clinical
rule. Specific aims are to: i) apply standardized clinical assessments to patients with chest pain,
incorporating results of early cardiac testing; ii) determine the inter-observer reliability of the
clinical information; iii) determine the statistical association between the clinical findings and the
composite outcome; and iv) use multivariable analysis to derive a highly sensitive clinical decision
rule to guide triage decisions.
Discussion: The study will derive a highly sensitive clinical decision rule to identify low risk
patients safe for early discharge. This will improve patient care, lower healthcare costs, and
enhance flow in our busy and overcrowded emergency departments.
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Patients with acute chest pain often undergo extensive
diagnostic testing and risk stratification to diagnose acute
coronary syndrome (ACS) and determine the likelihood
of future adverse cardiac events. Chest pain can be either
cardiac or noncardiac in etiology and represents a contin-
uum of risk from benign self-limiting conditions to life-
threatening illness requiring rapid diagnosis and treat-
ment. Currently it is not well established which patients
require extensive diagnostic investigation. The goal of this
study is to derive a clinical decision rule that predicts
adverse cardiac events with a high degree of sensitivity and
which will allow emergency physicians to accurately iden-
tify patients with chest pain who are safe for early dis-
charge without provocative testing.
Definition and epidemiology of acute coronary syndromes
ACS is a term that encompasses the disease entities unsta-
ble angina pectoris, non-ST-segment elevation myocardial
infarction (NSTEMI), and ST-segment elevation myocar-
dial infarction (STEMI). Although myocardial infarction
has been defined by a number of clinical, electrocardio-
graphic (ECG), and biochemical characteristics, it is gen-
erally agreed that the term indicates death of cardiac
myocytes due to prolonged ischemia [1]. Unstable angina
pectoris, on the other hand, indicates myocardial
ischemia without biochemical evidence of cardiac myo-
cyte death [2].
Data from the 2004 National Hospital Ambulatory Medi-
cal Care Survey indicate that chest pain is the second most
common chief complaint in North American emergency
departments, accounting for 6 million patient visits [3].
Approximately 565,000 patients are ultimately diagnosed
with acute myocardial infarction, and nearly twice as
many are diagnosed with unstable angina pectoris [4-6].
Statement of the problem in the emergency department
Chest pain is a diagnostic dilemma for the emergency
physician. Data from a recent Canadian study suggest that
4.6% of patients with acute myocardial infarction and
6.4% of patients with unstable angina are misdiagnosed
in the emergency department [7], with slightly lower rates
reported in the U.S. (2.1% and 2.3%, respectively) [8]. In
patients without a prior cardiac history, the challenge is to
determine if the chest pain is cardiac in etiology. In
patients with a prior cardiac history, the challenge is to
determine the short-term risk of adverse outcome.
Information obtained from the history, initial 12-lead
ECG, and a single set of cardiac enzymes to detect myocar-
dial necrosis is unable to identify patients who are safe for
early discharge with sufficient sensitivity [9,10]. Neither
the 2007 ACC/AHA guidelines for the management of
patients with unstable angina and NSTEMI nor the practi-
cal implementation of the 2002 AHA guidelines for the
emergency department proposed by Gibler et. al identify
a group of patients at very low risk for adverse cardiac
events who can be safely discharged without provocative
testing [11,12]. In the absence of guidelines that accu-
rately and reliably identify patients safe for early dis-
charge, physicians' triage decisions are variable and often
influenced by level of perceived medical and legal risk
[13-15]. As a result patients at very low risk for adverse
outcome are often triaged to chest pain observation units
and undergo extensive risk stratification protocols based
on an unstructured assessment of pretest probability and
perceived legal risk [16]. High sensitivity is ensured at the
expense of specificity, with increased likelihood of false
positive provocative testing and significant cost to the
healthcare system.
Methodologic standards for clinical decision rules
Concomitant with the reporting of various decision rules
has been an interest in the methodological standards for
their development and validation [17,18]. These stand-
ards may be summarized as follows: 1) The outcome or
diagnosis to be predicted must be clearly defined and the
assessment of this outcome should be made in a blinded
fashion. 2) The clinical findings to be used as predictors
must be clearly defined and standardized and their assess-
ment must be done without knowledge of the outcome.
3) The reliability or reproducibility of the clinical findings
used as predictors must be demonstrated. 4) The subjects
in the study should be selected without bias and should
represent a wide spectrum of clinical and demographic
characteristics to increase the generalizability of the
results. 5) The mathematical techniques for deriving the
rule must be identified. 6) Clinical decision rules should
be sensible: have a clear purpose, be relevant, demonstrate
content validity, be concise, and be easy to use in the
intended clinical application. 7) The accuracy of the deci-
sion rule in classifying patients with (sensitivity) and
without (specificity) the targeted outcome should be
demonstrated. 8) Prospective validation on a new set of
patients is an essential test of accuracy because misclassi-
fication is commonly higher when decision rules are
tested on a population other than the original derivation
set. 9) Implementation to demonstrate the true effect on
patient care is the ultimate test of a decision rule; trans-
portability can be tested at this stage.
Review of previous studies
Currently, there is no decision rule that is widely used in
Canadian and U.S. emergency departments. Although a
number of studies have been published that risk stratify
patients who present to the emergency department with
chest pain, none that directly address the clinical question
at hand could be considered methodologically robust
according to the criteria described previously [19]. SomePage 2 of 10
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following paragraphs.
The specific outcome measures varied considerably
among the studies, consisting of acute myocardial infarc-
tion alone [20-32], acute myocardial infarction and unsta-
ble angina [33-37], acute myocardial infarction and death
[38-40], all-cause mortality, acute myocardial infarction,
and need for revascularization [10,41-50], and similar
composite outcomes with slight variations [19,51-63].
Most studies did not report assessing the outcome without
knowledge of the predictor variables.
Fourteen studies reported assessing the predictor variables
in a standardized fashion with a data collection sheet spe-
cifically designed for a prediction rule study
[19,22,23,25,26,31,33,34,47,50,56-59]. However, only
four explicitly reported collecting the predictor variables
without knowledge of the outcome [19,50,56,57].
Only one study assessed the reliability of the clinical find-
ings to be used as predictors in the rule [19]. However, this
study did not report kappa values for the predictor varia-
bles considered for inclusion in the rule.
The definition of subjects in previous studies has been
extremely variable making it difficult for physicians to
interpret and apply the findings to their own patients. Sev-
eral studies did not specify age criteria for enrolment
[23,27-31,33,35,39-41,44,45,48-50,52,55,56,58,60].
Among those that did specify age criteria, different criteria
were used: over the age of 18 [21,22,34,38,54,59,63], over
the age of 20 [43,46], over the age of 24 [10,24,47], over
the age of 25 [19,25,26,53], over the age of 30
[32,36,42,51,61], between 20 and 80 years of age [62],
and between 24 and 39 years of age [57,64]. In some stud-
ies all patients with a primary complaint of chest pain
were eligible for enrolment [19,21,22,24-29,31-
34,43,44,46,49,53,54], whereas others required addi-
tional or different eligibility criteria
[10,23,24,30,35,36,38-42,45,47,48,50-52,54-63,65].
Exclusion criteria varied greatly among the studies as well.
The mathematical techniques were described in all of the
studies except one [31]. Several studies developed predic-
tion rules that lacked clinical sensibility and were not eas-
ily used in the intended clinical application [21-
31,33,34,36,50,52,59,61,62]. Twenty-four studies
reported the accuracy of the decision rule in terms of sen-
sitivity and specificity in diagnosing the predicted out-
come [10,19,21-30,32-35,45,49,50,54,59,60,62,65].
Twelve prediction rules have been prospectively validated
on a different set of patients from which the rule was
derived [21,22,25,26,34,37,42,53,55,57,61,65]. None of
these have consistently performed with sensitivities of ≥
98% across studies [66]. Only three prediction rules have
been implemented to demonstrate their true effect on
patient care [25,36,56]. The clinical decision rule devel-
oped by Goldman et al. [25] had a sensitivity of 88% doc-
umented in the implementation phase, and the outcome
was limited to acute myocardial infarction. Sensitivities as
low as 62% have been reported for the decision rule by
Selker et al. [36]. Finally, the decision rule developed by
Reilly et al. [56] addressed the decision of whether to
admit emergency department patients with chest pain to
the hospital ward or intensive care unit, not whether to
discharge a patient home or arrange additional observa-
tion and diagnostic testing.
Objectives
The goal is to derive a clinical decision rule that is highly
sensitive for predicting adverse cardiac events and which
will allow emergency department physicians to accurately
identify patients with chest pain who are safe for early dis-
charge without prolonged emergency department obser-
vation, hospital admission, or provocative testing.
Specific objectives are: 1) To develop and pretest stand-
ardized clinical assessment methods for patients with
acute chest pain, incorporating results of initial cardiac
testing. 2) To apply these standardized clinical assess-
ments to patients with chest pain. 3) To determine the
interobserver reliability of the clinical findings. 4) To
determine the association between the clinical findings
and the development of adverse cardiac events within 30
days. 5) To use multivariate techniques to derive a highly
sensitive clinical decision rule for patients with chest pain
to guide triage decisions and selection of further diagnos-
tic testing. 6) To assess the classification performance of
the derived decision rule. 7) To determine emergency phy-
sicians' accuracy in predicting acute coronary syndrome
without the decision rule.
Methods/design
Study design and setting
This will be a prospective cohort study in which consecu-
tive emergency department patients with a chief com-
plaint of chest pain and possible ACS will be enrolled. The
study will be conducted a tertiary care academic emer-
gency department in Ottawa, Ontario, Canada with an
annual census of approximately 60,000 patient visits.
Study population
All adult patients at least 25 years of age with a primary
complaint of chest pain of at least 5 minutes duration and
possible ACS will be eligible for enrolment. Patient eligi-
bility will be determined by the attending emergency phy-
sician on duty based on clinical judgment.Page 3 of 10
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met: 1) Acute ST-segment elevation (≥ 0.1 mV in limb
leads or ≥ 0.2 mV in precordial leads) on the initial ECG.
2) Hemodynamic instability or tachycardia (systolic
blood pressure < 90 mmHg, bradycardia < 50 beats/min,
tachycardia > 100 beats/min). 3) Pulmonary edema on
chest x-ray. 4) Age < 25 years. 5) A history of cocaine use
or positive test for cocaine. 6) Severe communication
problems such that a reliable history cannot be obtained.
7) A clear traumatic etiology of the chest pain. 8) A radio-
logically-evident cause of chest pain on chest x-ray (e.g.,
pneumonia, pneumothorax). 9) Prior enrolment in the
study within the past 30 days. 10) Terminal non-cardiac
illness. 11) No available phone contact. 12) Pregnancy.
Patient assessment
All patient assessments will be made by staff physicians
who are certified in emergency medicine by the Royal Col-
lege of Physicians and Surgeons in Canada and/or the
College of Family Physicians of Canada. Rotating house-
staff will perform patient assessments per standard prac-
tice but will be asked to have the staff physicians perform
study assessments. The primary investigator will orient
each of the physician assessors individually and provide
one-on-one training to ensure uniform data collection. All
physicians will complete data collection forms after
assessing the patient and before obtaining results of diag-
nostic tests, without knowledge of the outcome.
Quality assurance
Throughout the duration of the study, the completeness
of data collection and compliance in patient enrolment
will be monitored. Physicians will be given regular feed-
back regarding their completeness of data collection. No
feedback regarding the reliability or accuracy of each of
the predictor variables will be given.
Selection of variables
The variables selected for assessment in the study were
chosen based on review of the literature, input from all
the investigators, and solicited feedback from the designa-
tor physicians. The number of variables collected was lim-
ited to ensure efficient completion of data forms in the
context of patient care and optimize physician compli-
ance. The variables to be collected on each patient are
listed in Tables 1 and 2.
Electrocardiogram interpretation and cardiac biomarker 
assessment
Investigators blinded to the final outcome will review all
ECG's in a structured format to identify the presence or
absence of ST segment elevation or depression (classified
as < 0.05 mV, 0.05 to 0.1 mV, and > 1.0 mV deviation) in
at least 2 contiguous leads, T-wave inversion (≥ 0.2 mV
when isolated or < 0.2 mV when in 2 or more contiguous
leads with dominant R waves), left bundle branch block,
right bundle branch block, or pathological Q-waves. Each
of these findings will be categorized as "known to be old"
Table 1: List of prospectively collected historical variables.
Demographics • Age (years)
• Date of emergency visit (d/m/y)
• Gender (male/female)
• Arrival by ambulance
Cardiac medications • Aspirin
• Clopidogrel
• Other anticoagulants (warfarin, aspirin/dipyridamole)
• Beta blockers
• Calcium channel blockers
• Nitroglycerin (or other nitrates)
• Angiotensin converting enzyme inhibitors
• Cholesterol-lowering drugs




• Family history of cardiac disease
• Smoking history
Cardiac history • Acute myocardial infarction
• Cardiac arrest
• Peripheral vascular disease
• Angina
• Ventricular tachycardia
• Known coronary artery disease
• Atrial fibrillation
• Congestive heart failure
• Stroke or transient ischemic attack
Chest pain characteristics • Duration and time of onset of longest episode (days, 
hours, minutes; a.m., p.m.)
• Was the pain present on arrival to the ED?
• Is the pain worse with exertion?
• Is the pain similar to previously diagnosed ischemia?
• Has there been 2 or more episodes of pain in the last 
24 hours?
• Where on the chest is the pain located?
• Does the pain radiate?
• Is the pain worse with movement or position?
• The physician's overall assessment of the pain (typical 
or atypical)
• Has the pain completely resolved?
• Is the pain present at rest?
• Is the pain pleuritic (sharp, worse with deep 
breathing)?
• Has there been a change in the usual pattern of angina 
within the last 24 hours?
• Did the pain recur during the ED visit?
• How would you describe the pain?
• Is the pain associated with nausea, vomiting, or 
diaphoresis?Page 4 of 10
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ECG will be categorized as normal, nonspecific ST-T wave
changes, abnormal but not diagnostic of ischemia, infarc-
tion or ischemia known to be old, infarction or ischemia
not known to be old, or consistent with acute myocardial
infarction (ST-segment elevation or new left bundle-
branch block). This ECG classification system is known to
have high inter-rater reliability and to correlate well with
30-day outcome rates of death, myocardial infarction, and
revascularization [67,68].
Cardiac troponin T (cTNT) has been reported to have a
higher sensitivity than CK-MB for diagnosis of acute myo-
cardial infarction [69], and current guidelines suggest
using cTNT as the sole cardiac marker to detect cardiac
ischemia [70]. Thus, the sole cardiac marker utilized in
this study will be cardiac cTnT (Elecsys Troponin T, Roche
Diagnostics, Indianapolis, Indiana). The 99th percentile of
the reference range is < 0.01 µg/L. The lowest concentra-
tion at which 10% imprecision is achieved (10% coeffi-
cient of variation) is 0.035 µg/L. Some have suggested
using the 10% coefficient of variation as the cutoff for
myocardial injury to increase specificity and exclude other
causes of cTNT elevation such as chronic kidney disease,
left ventricular hypertrophy, pulmonary embolism, or
sepsis [71,72]. However, several studies have shown that
any detectable elevation in cTNT identifies patients at
high risk for ischemic complications, and a rising or fall-
ing pattern of cTNT can distinguish acute from chronic
disease [73-76]. In a robust emergency department trial by
Hamm et al. almost every patient at short term risk (30
days) was identified by elevations in cTNT above the 99th
percentile [74]. Use of the 99th percentile independent of
the coefficient of variation has a very low false positive
rate for diagnosing acute myocardial infarction and has
recently been validated [77]. Thus, 0.01 µg/L will be the
cutoff for a diagnosis of acute myocardial infarction.
These reference values conform to the ESC/ACC guide-
lines for use of existing assays clinically and for clinical tri-
als [2,70].
Having at least a 6 hour interval between cTNT specimens
is the AHA definition of an adequate set of biomarkers
[2,78]. However, recent data suggest that specimens
drawn at least 3 hours apart have the same rate of detec-
tion of acute myocardial infarction as the AHA schedule,
as long as at least one specimen is drawn ≥ 6 hours after
pain onset [79]. Thus, cTNT will be measured at emer-
gency department arrival and ≥ 6 hours from pain onset,
with at least 3 hours between samples [79].
Run-in period
The data collection forms, patient assessment techniques,
and patient follow-up questions will be evaluated during
an 8-week run-in period prior to the actual study. This will
allow time for training of the physician assessors and revi-
sion of the data collection forms as appropriate.
Interobserver reliability
A subset of patients will be assessed by a second emer-
gency physician who will be blinded to the results of the
first assessment. These second assessments will be per-
formed on a feasibility basis whenever two study physi-
cians are available.
Outcome measures
The primary outcome will be acute myocardial infarction,
death of cardiac or unknown cause, or revascularization
within 30 days of the emergency department visit. The sec-
ondary outcome will be acute myocardial infarction,
Table 2: List of variables to be prospectively collected from the physical examination and diagnostic tests.
Variables to be Collected
Physical Examination • Temperature (degrees Celsius)
• Heart rate (beats per minute)
• Systolic blood pressure (mm of Hg)
• Diastolic blood pressure (mm of Hg)
• Cardiac auscultation findings (S3, S4, Systolic murmur, diastolic murmur)
• Lung auscultation findings (crackles/
rales at bases, crackles/rales to scapulae, 
wheezes)
• Chest wall tenderness (reproducing 
presenting symptom)
• Pitting edema in lower extremities
Diagnostic tests • Intepretation of first readable ECG (normal, nonspecific ST-T wave 
changes, abnormal but not diagnostic of ischemia, infarction or ischemia 
known to be old, infarction or ischemia not known to be old, consistent 
with AMI (ST-elevation or new left bundle branch block)
• Cardiac stress test done
• If yes, type of stress test (nuclear, exercise, stress echo, other)
• If yes, result (positive for ischemia, negative for ischemia, equivocal)
• If equivocal, mild ischemia, moderate ischemia, or severe ischemia?
• Time and values of first and second 
cardiac troponin T
• Cardiac CT done?
• If yes, any stenosis ≥ 70%?
• Coronary angiography done?
• If yes, any stenosis ≥ 70%?
• Did the patient undergo 
revascularization?
• If yes, stent placement, angioplasty 
alone, or coronary artery bypass grafting?
Physician judgment • Probability of unstable angina or acute myocardial infarction (to the closest 
percent)Page 5 of 10
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new perfusion defect demonstrated on myocardial per-
fusion imaging.
Acute myocardial infarction will be defined as any one of
the following: (1) a cardiac troponin T (cTnT) ≥ 0.01 with
a rising or falling pattern (defined as a change of ≥ 0.03
ng/mL for values that are initially <0.2 ng/mL; for levels ≥
0.20 ng/mL, a positive cTnT will be defined as a change of
≥ 20% between samples)[1,72,80] or (2) development of
pathological Q-waves on the ECG or ECG evolution con-
sistent with acute myocardial infarction. Revasculariza-
tion will be defined as reestablishment of coronary artery
patency by percutaneous coronary angioplasty with or
without stent placement or coronary artery bypass graft
(CABG) surgery. The final component of the primary out-
come will be death of cardiac or unknown cause within 30
days of the emergency department visit.
The primary outcome will be determined by investigators
blinded to the knowledge of the predictor variables. If a
diagnosis cannot be assigned, 2 coinvestigators will
review all clinical data and assign an adjudicated outcome
diagnosis. If a consensus can not be reached between two
co-investigators, an adjudicated diagnosis will be assigned
by the primary investigator. If all 3 disagree, the final diag-
nosis will be the most significant diagnosis. The reliability
of the primary outcome determination will be assessed by
having all positive outcomes and 10% (randomly
selected) of patients with negative outcomes reviewed by
an investigator blinded to the first interpretation.
Data analysis
Interobserver agreement for each variable will be meas-
ured by calculating the kappa coefficient, the proportion
of potential agreement beyond chance, along with 95%
confidence intervals. Variables with kappa values ≥ 0.6
will be considered to represent "substantial agreement"
and considered for inclusion in the clinical rule.
Univariate analysis
Univariate analysis will be used to determine the strength
of association between each variable and the primary out-
come. The appropriate univariate technique will be cho-
sen for the type of data: for nominal data, the chi-square
test with continuity correction; for ordinal variables, the
Mann-Whitney U test; and, for continuous variables, the
unpaired 2-tailed t-test, using pooled or separate variance
estimates as appropriate.
Multivariable analysis
Multivariable analysis will be used to derive a model to
predict the primary outcome. Variables found to be both
reliable (kappa ≥ 0.6) and strongly associated with the pri-
mary outcome (p < 0.05) will be evaluated with both
logistic regression and recursive partitioning. Second
order interaction among predictor variables that are
known to be clinically related will be evaluated using
Mantel-Haenszel and logistic model procedures. Appro-
priate composite variables will be considered for incorpo-
ration in the multivariate analyses. The objective will be to
find the best combination of predictor variables that are
highly sensitive for detecting the primary outcome while
achieving the maximum possible specificity. To be clini-
cally acceptable, the model must be nearly 100% sensitive
and contain the fewest number of predictor variables to
facilitate ease of use by clinicians.
Recursive partitioning will be performed using Knowledg-
eSEEKER Version 5.2 software (Angoss Software Interna-
tional, Toronto) [81-83]. In recursive partitioning, the
relationship between a dependent outcome variable (Y)
and a series of predictor variables (X) is defined by a series
of binary splits, resulting in a decision tree in which data
are partitioned into several nodes or leaves along
branches. The significance of each binary split can be
quantified based on the chi-square technique.
Attempts to find the best model will also be made by per-
forming logistic regression as an alternative technique.
Model building will proceed with forward stepwise selec-
tion until no variables meet the entry (0.05) or removal
(0.10) criteria for the significance level of the likelihood
ratio test. In order to provide a simpler model for clini-
cians, cutpoints will be sought for continuous variables.
The variables chosen by the best model will constitute the
decision rule.
Classification performance
The derived decision rule will be evaluated by comparing
the classification of each patient to their actual status for
the primary outcome. This will enable an estimate of the
sensitivity and specificity of the rule, with 95% confidence
intervals.
Patient subgroups
The classification performance of the decision rule will be
assessed in the following patient subgroups: a) patients
with and without a prior cardiac history b) patients with
ECG's classified as normal or nonspecific ST-T wave
changes and negative cardiac biomarkers and c) patients
with outcomes at 0, 4, 14, and 30 days from the emer-
gency department visit.
Physician judgment
Data from questions relating to physicians' predictions
will be tabulated and presented in descriptive format. The
probability will be used to calculate a receiving operating
characteristic (ROC) curve for the diagnosis of acute coro-
nary syndrome.Page 6 of 10
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Excluding the run-in stage, 1200 patients will be enrolled
over 12 months at the study hospitals during phase I.
Since no hypothesis is being tested, the sample size is
based on estimation of the precision of the sensitivity of
the derived decision rule as well as on the precision of the
estimates of interobserver variability and the logistic
regression coefficients. The sample size has to accommo-
date a large number of clinical variables (31), a large
number of physicians (more than 60), the prevalence of
acute coronary syndrome (21% of eligible patients in two
recent Canadian studies [7,19]), as well as our plans to
assess subgroups. A sample size of 1200 patients with pos-
sible ACS in which 11% of cases are excluded for ST seg-
ment elevation should yield approximately 120 ACS
cases. 120 cases are needed to derive a rule that is 100%
sensitive with upper and lower 95% confidence limits of
100% and 97.0%, respectively.
Ethics approval
Research ethics board approval was obtained from The
Ottawa Hospital. As the study will not affect usual prac-
tice, there were no specific ethical concerns. At enrolment,
participants will be informed that they will be contacted
by phone in one month to determine their status, and ver-
bal consent will be obtained at the time of the follow-up
phone call. Personal identifiers will be removed from clin-
ical records where present and not stored in the study
database.
Discussion
Chest pain is a diagnostic dilemma for the emergency
physician. In the absence of an accurate and reliable
method of identifying patients at very low risk for adverse
cardiac events, physicians' triage decisions are variable
and often influenced by level of perceived medical and
legal risk [15]. As a result very low risk patients are triaged
to chest pain observation units and undergo extensive risk
stratification protocols based on an unstructured assess-
ment of pretest probability and perceived legal risk [16].
Despite this inefficiency, a number of emergency depart-
ment patients at risk for adverse cardiac events are being
missed [8].
We aim to derive a clinical decision rule that is highly sen-
sitive for predicting acute myocardial infarction, need for
revascularization, or death within 30 days of presentation
to the emergency department using techniques success-
fully applied to ankle, knee, and cervical spine radiogra-
phy [84-86]. Future plans are to prospectively validate the
derived rule in new set of patients. This will improve
patient care, lower healthcare costs, and improve flow in
our busy and overcrowded emergency departments.
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